Anzeige
Meldung des Tages: 1 Billion Dollar reichen nicht: Europas kritisches Rohstoffproblem
Neuester, zuletzt geles. Beitrag
Antworten | Hot-Stocks-Forum
Übersicht ZurückZurück WeiterWeiter
... 45 46 47 49 50 51 ...

Amarantus Bioscence - WKN: A1J9ZB - MEGA NEWS $$$$


Beiträge: 1.673
Zugriffe: 229.811 / Heute: 48
Amarantus BioSc. 0,000001 $ +0,00% Perf. seit Threadbeginn:   -100,00%
 
schultebrand:

trendwende in sicht ?

 
01.03.13 17:50
Real-Time Best Bid & Ask
0.0775 / 0.0779 (1 x 1)Why is size 1?
Antworten

Werbung

Entdecke die beliebtesten ETFs von Xtrackers

Xtrackers MSCI Korea UCITS ETF 1C
Perf. 12M: +99,62%
Xtrackers CSI500 Swap UCITS ETF 1C
Perf. 12M: +58,13%
Xtrackers Spain UCITS ETF 1D
Perf. 12M: +55,77%
Xtrackers Spain UCITS ETF 1C
Perf. 12M: +55,58%
Xtrackers MSCI EM Latin America ESG Swap UCITS ETF 1C
Perf. 12M: +50,08%

Goldesel2010:

jep...

 
01.03.13 17:51
Es geht mal wieder in die richtige Richtung...
Antworten
schultebrand:

wurde auch zeit.....

 
01.03.13 17:52
Antworten
berliner-nobo.:

sollte nun wirklich starten

 
01.03.13 18:18
(Verkleinert auf 80%) vergrößern
Amarantus Bioscence - WKN: A1J9ZB - MEGA NEWS $$$$ 583769
Antworten
schultebrand:

schön wäre ein sk über 0,10$.......

 
01.03.13 18:24
aber da wollen wir mal nicht zu viel verlangen.
Antworten
Obelax:

sollten heut nicht news kommen?

 
01.03.13 18:26
Antworten
nordküstenbau:

bin dabei

 
01.03.13 18:26
sieht saustark aus
Antworten
Zocker24:

so

 
01.03.13 18:31
bin auch dabei. Uns allen viel Glück
Antworten
schultebrand:

na dann kanns ja losgehen....

 
01.03.13 18:38
aber die herztropfen nicht vergessen......geht schon mal recht turbulent zu, bei amarantus..
Antworten
nordküstenbau:

Amarantus Bio

 
01.03.13 18:42
0,0799 USD
01.03.13  18:41
Antworten
berliner-nobo.:

der chart welcher aus sieht wie handgemacht

 
01.03.13 18:43

und sich wohl wieder holen wird nur noch höher :)

Amarantus Bioscence - WKN: A1J9ZB - MEGA NEWS $$$$ 583773
Antworten
nordküstenbau:

Amarantus Bio

 
01.03.13 18:44
im Chartverlauf erkennt man genau das bisherige Hoch bei 0,18 USD
Antworten
berliner-nobo.:

sollten die nächsten phasen erreicht

 
01.03.13 18:46
werden der diagnostic programm oder manf zu kllinischen studien zu gelassen, kannst du das hoch vergessen
Antworten
nordküstenbau:

Amarantus Bio

 
01.03.13 19:16
alles ist möglich bei den Amigos, 0,1 USD heute?
Antworten
berliner-nobo.:

10 cent heute

 
01.03.13 19:22
wäre der knaller.

ich denke so oder so das sie diagnostic sparte bei marktreife verkaufen werden
Antworten
schultebrand:

#1189 du meinst 50% aufschlag.......?

 
01.03.13 19:23
bin zwar optimistisch......wäre aber schon toll wenn sich dieses niveau halten würde.
Antworten
berliner-nobo.:

intern geschätzer marktwert

 
01.03.13 19:24
800 usdollar alles nach zulesen auf der homepage

bei 225 mio aktien, das hat potenzial

und dann werden sie sich nur auf manf konzentrieren

geschätzer markt wert auch intern 5 milliarden usdollar
Antworten
Lanki 67:

News

 
02.03.13 08:43
ih.advfn.com/p.php?pid=nmona&article=56536413
Antworten
mariosapf:

berlin

 
02.03.13 09:00
hallo,

sind die aktien in berlin noch handelbar? gestern gab es ja keine umsätze !?

danke für die info !
Antworten
sauerland1502:

Kurse werden gestellt, Handel ist aber bis auf

 
02.03.13 09:45
weiteres eingestellt! Musste drüben kaufen!
Antworten
Zocker24:

guter Support bei 0,07

2
02.03.13 09:55
www.stockta.com/cgi-bin/...mb=AMBS&cobrand=&mode=stock
Antworten
schultebrand:

läuft weiter.......

 
04.03.13 16:01
aktuell

Real-Time Best Bid & Ask
0.084 / 0.085 (1 x 1)Why is size 1?
Antworten
File083:

So.

 
04.03.13 16:37

bin auch mal drin..mal schauen was hier so geht.. Weiß einer was zum Termin am 06.03?

Antworten
berliner-nobo.:

hier kann viel gehen

 
05.03.13 23:57

Short Term Indicators Average: 40% Buy Medium Term Indicators Average: 25% Sell Long Term Indicators Average: 67% Buy Overall Average: 16% Buy MACD kreutzt bulish

 

http://www.barchart.com/quotes/stocks/AMBS

Amarantus BioScience, Brewer Sports International and TCMG Announce #C4CT Concussion Awareness Conference
Amarantus Bioscence - WKN: A1J9ZB - MEGA NEWS $$$$ 584906
Related Stocks

AMBS - Amarantus Biosci Inc

Amarantus       BioScience, Inc. (OTCQB: AMBS), a biotechnology company discovering       and developing treatments and diagnostics for diseases associated with       the neurodegeneration and apoptosis centered around its patented       therapeutic protein MANF, Brewer       Sports International (BSI) and Toi Cook Management Group (TCMG)       today announced joint hosting of the Coalition for Concussion Treatment       (#C4CT) Concussion Awareness Conference (#C4CT Conference) in       Minneapolis on June 19, 2013 at the Minneapolis Club.

The #C4CT Conference is the opening event of the three-day Brewer Sports       Symposium, which also includes the 3rd Annual Sports Law for       Rookies and Veterans CLE and Sports and Social Impact seminar. The #C4CT       Conference will focus on important scientific, medical, translational       and prevention-related topics of Traumatic Brain Injuries (TBI) and       their long-term impacts on athletes and soldiers. Conference panels will       include industry experts, international business leaders and current and       former professional athletes. The Brewer Sports Symposium is part of the 8th       Annual Blue Carpet Celebrity Weekend hosted by The Jack Brewer       Foundation.

"Traumatic Brain Injuries and their effects on amateur and professional       football players are emerging as a rallying point to better understand       the brain and how we can improve currently available methods to treat       it," said Gerald E. Commissiong, President and CEO of AMBS. "We are       proud to be among the first to unite the groups directly affected by       these issues, in particular current and former professional athletes,       with the scientists, physicians and entrepreneurs who will ultimately       lead the way in developing solutions to these devastating problems. We       believe that by educating athletes on the basics of concussions, and       what additional resources are needed to achieve certain critical steps       on the road to better treating the brain, we will give all parties a       chance to partake in this emerging field of medical research."

The #C4CT Conference will include presentations and panel discussions on       the following key topics:

--        Scientific understanding of Traumatic Brain Injury and the long-term         scientific implications

--        Current medical practice and what doctors believe are the key areas of         unmet medical need

--        Translational models available and additional tools needed to         accelerate research

--        Innovative approaches currently being considered

Jack Brewer, CEO of BSI, explains, "When advising athletes, we       frequently get the question of how to deal with concussions as well as       the desire to better understand the issue at hand and how to help. As an       ex-NFL player, I personally have experienced hundreds of violent       collisions throughout my career and have several teammates and friends       who suffer the lasting effects of Traumatic Brain Injury. This is a       passion of mine and BSI is committed to helping advance TBI research and       development. By providing educational opportunities such as the #C4CT       Conference, it is our goal to enable those directly impacted to make       informed decisions as well as provide tangible investment opportunities       surrounding the advancement of research and treatment methods for       concussions."

Toi Cook, Amarantus Advisor, former Super Bowl champion with the 1994       San Francisco 49ers and 11 year starting NFL defensive back said, "As a       player representative for the entirety of my NFL career, my focus was       the welfare and safety of the players. Although the current situation in       professional sports regarding concussions is alarming and has raised       serious issues, I am encouraged by the fact that we are all now much       more aware of the problem and need for solutions. Now is the time to       act, and through our work with partners like Amarantus and BSI and with       conferences such as #C4CT, we can make a difference and impact lives       while maintaining the integrity of sport."

(Verkleinert auf 80%) vergrößern
Amarantus Bioscence - WKN: A1J9ZB - MEGA NEWS $$$$ 584906
Antworten
berliner-nobo.:

interessant

 
06.03.13 12:27

RBCC Nears Finalization of Partnership Agreement with Leading-Edge Pharmacogenomics Labs

2013-03-06 05:00 ET - News Release

 

NOKOMIS, Fla. -- (Business Wire)

Rainbow Coral Corp. (OTCBB: RBCC), a biotech company focused on delivering new medical technologies and innovations, today reports its anticipation of partnering with a cutting-edge genome-mapping facility in Houston in the next few weeks.

The genetic testing sector is one of the fastest-growing segments of the global biotech industry, with some market experts expecting it to reach $2.2 billion by 2017. The cutting-edge science of pharmacogenomics is a field of study resulting from the Human Genome Project that seeks to help doctors assess genetic variations in patients in order to create more effective, optimized drug treatment plans.

RBCC sees it as the future of medicine.

“This is the next evolution in personalized medicine,” said RBCC CEO Patrick Brown. “Important differences in drug metabolism and response from person to person are often rooted in our genes. By studying a patient’s genotype, doctors can eliminate the trial-and-error approach to tailoring a safer, more efficient and more effective drug treatment plan.”

RBCC is turning its full attention to the exploration of new promising opportunities now that the company will no longer be partnering with Amarantus Biosciences, which has elected to pursue other opportunites. RBCC wishes Amarantus much success moving forward, and remains open to future partnering opportunities with the company.

In addition to its pharmacogenomics talks, RBCC is also currently working on a joint venture agreement with a privately held drug delivery company that could soon make local delivery of biologic agents and small molecules safer, more effective and more convenient than ever before.

For more information on Rainbow BioSciences’ current projects, please visit www.rainbowbiosciences.com/investors.html.

Rainbow BioSciences will develop new medical and research technology innovations to compete alongside companies such as Bristol Myers Squibb Co. (NYSE: BMY), Biogen Idec Inc. (NASDAQ: BIIB), Abbott Laboratories (NYSE: ABT) and Amgen Inc. (NASDAQ: AMGN).

http://www.stockwatch.com/News/...6&symbol=RBCC&news_region=U

Antworten
Auf neue Beiträge prüfen
Es gibt keine neuen Beiträge.

Seite: Übersicht ... 45 46 47 49 50 51 ... ZurückZurück WeiterWeiter

Hot-Stocks-Forum - Gesamtforum - Antwort einfügen - zum ersten Beitrag springen

Neueste Beiträge aus dem Amarantus BioScience Forum

Wertung Antworten Thema Verfasser letzter Verfasser letzter Beitrag
3 1.672 Amarantus Bioscence - WKN: A1J9ZB - MEGA NEWS $$$$ Antont Dr.Schuh 25.04.21 03:33
  8 Ein Milliarden Dollar Unternehmen wurde geboren? sauerland1502 krauty77 11.01.13 09:00
3 137 Ein Milliarden Dollar Unternehmen wurde geboren? sauerland1502 wamu2009 02.01.13 16:28
  30 Amarantus BioSciences in aller Munde Balu4u madeinhell 18.12.12 08:29

--button_text--